KIRAN JUDGE: Open Payments
NPI 1831792647 · FAIRFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 61 payments from 25 companies in 2025. Trend: 2023 $808 · 2024 $980 · 2025 $1,502
Food & beverage: $1,493Education: $9
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 6 | $235 |
| Novo Nordisk Inc | 9 | $167 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $151 |
| GENZYME CORPORATION | 4 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Lilly USA, LLC | 3 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| Exact Sciences Corporation | 3 | $68 |
| Amgen Inc. | 3 | $61 |
Products named: DUPIXENT, JARDIANCE, DEXCOM G7 GSS (161), Dexcom G6 Transmitter, Ozempic, Kerendia, MOUNJARO, GVOKE HYPOPEN.
Industry payments across CA — which companies pay providers there.
